About 6 results found for searched term "L-CCG-l" (0.144 seconds)
Cat.No. | Name | Target |
---|---|---|
M6898 | L-CCG-l | Others |
L-CCG-l is a potent group II mGlu agonist. | ||
M8533 | CCG-203971 | Ras |
CCG-203971 is a second-generation Rho/MRTF/SRF pathway inhibitor. CCG-203971 potently targets RhoA/C-activated SRE-luciferase (IC50 =6.4 μM). CCG-203971 inhibits PC-3 cell migration with an IC50 of 4.2 μM. | ||
M14052 | CCG-100602 | Ras |
CCG-100602 is a specific inhibitor of myocardin-related transcription factor A/serum response factor (MRTF-A/SRF) signaling. CCG-100602 specifically block MRTF-A nuclear localization and thus inhibit the fibrogenic transcription factor SRF. | ||
M16986 | Kobusin | GLUT |
Kobusin, a dioxygenated lignan isolated from Pnonobio biondii Pamp, is also an activator of the CFTR and CaCCgie chloride channels and an inhibitor of the ANO1/CaCC (calcium-activated chloride channel) channel. | ||
M52788 | cis-α-(Carboxycyclopropyl)glycine | EAAT |
cis-α-(Carboxycyclopropyl)glycine (L-CCG III) is a potent, competitive glutamate uptake inhibitor. | ||
M56296 | CCG258747 | Opioid Receptor |
CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the µ-opioid receptor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.